Gelatinous transformation of marrow in a case of acute myelogenous leukemia post-chemotherapy.
Gelatinous transformation of marrow in a patient with acute myelogenous leukemia was reported. This case was at variance with other reported cases of gelatinous transformation of marrow in that a) it was associated with a primary bone marrow disease and b) there was no fat atrophy and the patient was not cachectic. The fact that it occurred abruptly post-chemotherapy suggested that marrow hypoplasia induced by chemotherapy could be the cause of this lesion in this particular situation.
Feng
C S
CS
Haematology Laboratory and Blood Bank, Prince of Wales Hospital, Shatin, Hong Kong.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001284:Atrophy; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged
D003561:Cytarabine; D006820:Hyaluronic Acid; D003630:Daunorubicin